{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:13:23Z","timestamp":1788311603966,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017949","name":"Health Commission of Shanxi Province","doi-asserted-by":"publisher","award":["Grant No. 2025ZD018"],"award-info":[{"award-number":["Grant No. 2025ZD018"]}],"id":[{"id":"10.13039\/100017949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-026-07734-x","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T02:47:15Z","timestamp":1782096435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning-guided risk stratification in elderly AML based on genomic, immunophenotypic and therapeutic profiles"],"prefix":"10.1186","volume":"26","author":[{"given":"Ling","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xialin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"10393","key":"7734_CR1","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","volume":"401","author":"CD DiNardo","year":"2023","unstructured":"DiNardo CD, Erba HP, Freeman SD, Wei AH. Acute myeloid leukaemia. Lancet. 2023;401(10393):2073\u201386.","journal-title":"Lancet"},{"issue":"5","key":"7734_CR2","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.27625","volume":"100","author":"S Shimony","year":"2025","unstructured":"Shimony S, Stahl M, Stone RM, Acute Myeloid L. 2025 Update on Diagnosis, Risk-Stratification, and Management. Am J Hematol. 2025;100(5):860\u201391.","journal-title":"Am J Hematol"},{"issue":"1","key":"7734_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","volume":"16","author":"RS Bhansali","year":"2023","unstructured":"Bhansali RS, Pratz KW, Lai C. Recent advances in targeted therapies in acute myeloid leukemia. J Hematol Oncol. 2023;16(1):29.","journal-title":"J Hematol Oncol"},{"issue":"10","key":"7734_CR4","doi-asserted-by":"publisher","first-page":"e2319366121","DOI":"10.1073\/pnas.2319366121","volume":"121","author":"JF Li","year":"2024","unstructured":"Li JF, Cheng WY, Lin XJ, Wen LJ, Wang K, Zhu YM, et al. Aging and comprehensive molecular profiling in acute myeloid leukemia. Proc Natl Acad Sci U S A. 2024;121(10):e2319366121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"7734_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11912-020-00964-1","volume":"22","author":"M Abdallah","year":"2020","unstructured":"Abdallah M, Xie Z, Ready A, Manogna D, Mendler JH, Loh KP. Management of Acute Myeloid Leukemia (AML) in Older Patients. Curr Oncol Rep. 2020;22(10):103.","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"7734_CR6","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1016\/S2352-3026(24)00033-4","volume":"11","author":"A Bazinet","year":"2024","unstructured":"Bazinet A, Garcia-Manero G, Short N, Alvarado Y, Bataller A, Abuasab T, et al. Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 study. Lancet Haematol. 2024;11(4):e276\u201386.","journal-title":"Lancet Haematol"},{"issue":"34","key":"7734_CR7","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1200\/JCO.23.02631","volume":"42","author":"J Versluis","year":"2024","unstructured":"Versluis J, Metzner M, Wang A, Gradowska P, Thomas A, Jakobsen NA, et al. Risk Stratification in Older Intensively Treated Patients With AML. J Clin Oncol. 2024;42(34):4084\u201394.","journal-title":"J Clin Oncol"},{"issue":"1","key":"7734_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41408-025-01258-0","volume":"15","author":"FW Hoff","year":"2025","unstructured":"Hoff FW, Huang Y, Welkie RL, Swords RT, Traer E, Stein EM, et al. Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial. Blood Cancer J. 2025;15(1):55.","journal-title":"Blood Cancer J"},{"issue":"6","key":"7734_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1182\/blood.2023022611","volume":"143","author":"VR Bhatt","year":"2024","unstructured":"Bhatt VR, Uy GL, Klepin HD. Determining treatment tolerance and fitness for intensive chemotherapy in older adults with AML: a call to action. Blood. 2024;143(6):483\u20137.","journal-title":"Blood"},{"issue":"11","key":"7734_CR10","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s11912-023-01450-0","volume":"25","author":"M Zimmer","year":"2023","unstructured":"Zimmer M, Kadia T. Approach to the Older Patient with Acute Myeloid Leukemia. Curr Oncol Rep. 2023;25(11):1203\u201311.","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"7734_CR11","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.1038\/s41467-025-60192-8","volume":"16","author":"R Almaghrabi","year":"2025","unstructured":"Almaghrabi R, Alyahyawi Y, Keane P, Mian SA, Habel K, Atkinson A, et al. A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progression. Nat Commun. 2025;16(1):5489.","journal-title":"Nat Commun"},{"issue":"12","key":"7734_CR12","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1182\/blood.2024024011","volume":"145","author":"SD Green","year":"2025","unstructured":"Green SD, Wang ES. How I treat secondary acute myeloid leukemia. Blood. 2025;145(12):1260\u201372.","journal-title":"Blood"},{"issue":"12","key":"7734_CR13","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377.","journal-title":"Blood"},{"issue":"21","key":"7734_CR14","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1182\/blood.2024025409","volume":"144","author":"H D\u00f6hner","year":"2024","unstructured":"D\u00f6hner H, DiNardo CD, Appelbaum FR, Craddock C, Dombret H, Ebert BL, et al. Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations. Blood. 2024;144(21):2169\u201373.","journal-title":"Blood"},{"issue":"20","key":"7734_CR15","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1182\/bloodadvances.2024013685","volume":"8","author":"FW Hoff","year":"2024","unstructured":"Hoff FW, Blum WG, Huang Y, Welkie RL, Swords RT, Traer E, et al. Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy. Blood Adv. 2024;8(20):5297\u2013305.","journal-title":"Blood Adv"},{"key":"7734_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.inffus.2018.09.012","volume":"50","author":"M Zitnik","year":"2019","unstructured":"Zitnik M, Nguyen F, Wang B, Leskovec J, Goldenberg A, Hoffman MM. Machine Learning for Integrating Data in Biology and Medicine: Principles, Practice, and Opportunities. Inf Fusion. 2019;50:71\u201391.","journal-title":"Inf Fusion"},{"issue":"25","key":"7734_CR17","first-page":"2398","volume":"388","author":"S Khan","year":"2023","unstructured":"Khan S. Artificial Intelligence and Machine Learning in Clinical Medicine. N Engl J Med. 2023;388(25):2398.","journal-title":"N Engl J Med"},{"key":"7734_CR18","doi-asserted-by":"publisher","first-page":"1487234","DOI":"10.3389\/fmed.2024.1487234","volume":"11","author":"SX Wang","year":"2024","unstructured":"Wang SX, Huang ZF, Li J, Wu Y, Du J, Li T. Optimization of diagnosis and treatment of hematological diseases via artificial intelligence. Front Med (Lausanne). 2024;11:1487234.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"7734_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12935-023-02905-x","volume":"23","author":"FM Zhong","year":"2023","unstructured":"Zhong FM, Yao FY, Yang YL, Liu J, Li MY, Jiang JY, et al. Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemia. Cancer Cell Int. 2023;23(1):61.","journal-title":"Cancer Cell Int"},{"key":"7734_CR20","doi-asserted-by":"crossref","unstructured":"Allegra A, Tonacci A, Sciaccotta R, Genovese S, Musolino C, Pioggia G, et al. Machine Learning and Deep Learning Applications in Multiple Myeloma Diagnosis, Prognosis, and Treatment Selection. Cancers (Basel). 2022;14(3):606.","DOI":"10.3390\/cancers14030606"},{"key":"7734_CR21","doi-asserted-by":"crossref","unstructured":"Nazha A, Elemento O, Ahuja S, Lam BD, Miles M, Shouval R, et al. Artificial intelligence in hematology. Blood. 2025;146(19):2283\u201392.","DOI":"10.1182\/blood.2025029876"},{"issue":"26","key":"7734_CR22","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1182\/blood.2024027287","volume":"145","author":"JC Hern\u00e1ndez-Boluda","year":"2025","unstructured":"Hern\u00e1ndez-Boluda JC, Mosquera-Orgueira A, Gras L, Koster L, Tuffnell J, Kr\u00f6ger N, et al. Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis. Blood. 2025;145(26):3139\u201352.","journal-title":"Blood"},{"issue":"11","key":"7734_CR23","doi-asserted-by":"publisher","first-page":"e70251","DOI":"10.1002\/hem3.70251","volume":"9","author":"Y Tao","year":"2025","unstructured":"Tao Y, Shen Y, Tang Y, Shi H, Wei L, You H. Integrating transcriptomic profiling and machine learning: A clinically actionable prognostic model for infant acute myeloid leukemia. Hemasphere. 2025;9(11):e70251.","journal-title":"Hemasphere"},{"issue":"1","key":"7734_CR24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1186\/s12877-023-04477-x","volume":"23","author":"A Das","year":"2023","unstructured":"Das A, Dhillon P. Application of machine learning in measurement of ageing and geriatric diseases: a systematic review. BMC Geriatr. 2023;23(1):841.","journal-title":"BMC Geriatr"},{"issue":"1","key":"7734_CR25","doi-asserted-by":"publisher","first-page":"e000262","DOI":"10.1136\/fmch-2019-000262","volume":"8","author":"MZI Chowdhury","year":"2020","unstructured":"Chowdhury MZI, Turin TC. Variable selection strategies and its importance in clinical prediction modelling. Fam Med Community Health. 2020;8(1):e000262.","journal-title":"Fam Med Community Health"},{"issue":"3","key":"7734_CR26","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/bjh.13971","volume":"176","author":"JL Coelho-Silva","year":"2017","unstructured":"Coelho-Silva JL, Carvalho LE, Oliveira MM, Franca-Neto PL, Andrade AT, Lima AS, et al. Prognostic importance of CD56 expression in intermediate risk acute myeloid leukaemia. Br J Haematol. 2017;176(3):498\u2013501.","journal-title":"Br J Haematol"},{"issue":"21","key":"7734_CR27","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1182\/blood-2018-12-889725","volume":"133","author":"D Sasca","year":"2019","unstructured":"Sasca D, Szybinski J, Sch\u00fcler A, Shah V, Heidelberger J, Haehnel PS, et al. NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML. Blood. 2019;133(21):2305\u201319.","journal-title":"Blood"},{"key":"7734_CR28","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Alvarez L, Mart\u00ednez-S\u00e1nchez ME, Gray E, P\u00e9rez-Figueroa E, Ortega E. Aminopeptidase N\/CD13 crosslinking promotes the activation and membrane expression of integrin CD11b\/CD18. Biomolecules. 2023;13(10):1488.","DOI":"10.3390\/biom13101488"},{"issue":"1","key":"7734_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41408-024-01186-5","volume":"14","author":"M Shahzad","year":"2024","unstructured":"Shahzad M, Amin MK, Daver NG, Shah MV, Hiwase D, Arber DA, et al. What have we learned about TP53-mutated acute myeloid leukemia? Blood Cancer J. 2024;14(1):202.","journal-title":"Blood Cancer J"},{"key":"7734_CR30","doi-asserted-by":"crossref","unstructured":"Shah MV, Arber DA, Hiwase DK. TP53-mutated myeloid neoplasms: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2025;100 Suppl 4(Suppl 4):88\u2013115.","DOI":"10.1002\/ajh.27655"},{"issue":"8","key":"7734_CR31","doi-asserted-by":"publisher","first-page":"9615","DOI":"10.1002\/cam4.5739","volume":"12","author":"H Liao","year":"2023","unstructured":"Liao H, Lai H, Chen J, Shuai X, Zhang X, Yang Y, et al. Prognostic value of cross-lineage expression of the myeloid-associated antigens CD13 and CD33 in adult B-lymphoblastic leukemia: A large real-world study of 1005 patients. Cancer Med. 2023;12(8):9615\u201326.","journal-title":"Cancer Med"},{"issue":"4","key":"7734_CR32","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/ajcp\/aqac083","volume":"158","author":"D Jevremovic","year":"2022","unstructured":"Jevremovic D, Nanaa A, Geyer SM, Timm M, Azouz H, Hengel C, et al. Abnormal CD13\/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance. Am J Clin Pathol. 2022;158(4):530\u20136.","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"7734_CR33","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1182\/blood.2019002779","volume":"135","author":"X He","year":"2020","unstructured":"He X, Feng Z, Ma J, Ling S, Cao Y, Gurung B, et al. Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia. Blood. 2020;135(10):713\u201323.","journal-title":"Blood"},{"issue":"19","key":"7734_CR34","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1182\/bloodadvances.2022008282","volume":"7","author":"S Zarnegar-Lumley","year":"2023","unstructured":"Zarnegar-Lumley S, Alonzo TA, Gerbing RB, Othus M, Sun Z, Ries RE, et al. Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis. Blood Adv. 2023;7(19):5941\u201353.","journal-title":"Blood Adv"},{"issue":"2","key":"7734_CR35","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41375-025-02851-9","volume":"40","author":"A Hern\u00e1ndez-S\u00e1nchez","year":"2026","unstructured":"Hern\u00e1ndez-S\u00e1nchez A, Villaverde Ramiro \u00c1, Str\u00e4ng E, Turki AT, Ab\u00e1igar M, Versluis J, et al. Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study. Leukemia. 2026;40(2):418\u201328.","journal-title":"Leukemia"},{"issue":"4","key":"7734_CR36","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41375-021-01425-9","volume":"36","author":"C R\u00e9cher","year":"2022","unstructured":"R\u00e9cher C, R\u00f6llig C, B\u00e9rard E, Bertoli S, Dumas PY, Tavitian S, et al. Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries. Leukemia. 2022;36(4):913\u201322.","journal-title":"Leukemia"},{"issue":"1","key":"7734_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cell.2024.10.045","volume":"188","author":"YT Deng","year":"2025","unstructured":"Deng YT, You J, He Y, Zhang Y, Li HY, Wu XR, et al. Atlas of the plasma proteome in health and disease in 53,026 adults. Cell. 2025;188(1):253\u2013. \u2013\u200971.e7.","journal-title":"Cell"},{"key":"7734_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.semcancer.2022.12.009","volume":"88","author":"X He","year":"2023","unstructured":"He X, Liu X, Zuo F, Shi H, Jing J. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine. Semin Cancer Biol. 2023;88:187\u2013200.","journal-title":"Semin Cancer Biol"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-026-07734-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07734-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07734-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:29:23Z","timestamp":1788308963000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-026-07734-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7734"],"URL":"https:\/\/doi.org\/10.1186\/s12877-026-07734-x","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Shanxi Bethune Hospital, approval number: YXLL-2025-046. Informed consent was obtained from all individual participants included in the study. For retrospective data, the requirement for written informed consent was waived by the ethics committee, and all data were anonymized prior to analysis.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data, images, or videos that would require consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1124"}}